Transplantation of embryonic nigral tissue ameliorates functional deficiencies in Parkinson's disease (PD). A main constraint of neural grafting is the poor survival of dopaminergic neurones grafted into patients. Studies in rats indicated that many grafted neurones die by apoptosis. CEP-1347 is a mixed-lineage-kinase (MLK) inhibitor with neuroprotective action in several in vitro and in vivo models of neuronal apoptosis. We studied the effect of CEP-1347 on the survival of embryonic rat dopaminergic neurones in culture, and after transplantation in hemiparkinsonian rats. CEP-1347 and the alternative MLK inhibitor CEP-11004 significantly increased the survival of dopaminergic neurones in primary cultures from rat ventral mesencephalon and in Mn 2+ -exposed PC12 cells, a surrogate model of dopaminergic lethal stress. Moreover, combined treatment of the grafting cell suspension and the host animal with CEP-1347 significantly improved the longterm survival of rat dopaminergic neurones transplanted into the striatum of hemiparkinsonian rats. Also, the protective effect of CEP-1347 resulted in an increase in total graft size and in enhanced fibre outgrowth. Thus, treatment with CEP-1347 improved dopaminergic cell survival under severe stress and might be useful to improve the positive outcome of transplantation therapy in PD and reduce the amount of human tissue required.
Transplantation of embryonic ventral mesencephalic tissue containing dopaminergic neurones is an effective treatment for Parkinson's disease (PD) (Kordower et al. 1998; Tabbal et al. 1998; Piccini et al. 1999; Brundin et al. 2000b; Lindvall and Hagell 2000; Freed et al. 2001) . However, one of the major restrictions of more widespread application of clinical transplantation is the limited availability of suitable donor tissue, combined with a poor survival of dopaminergic cells in the grafts, i.e. a maximum of 5 10% in rats, monkeys and human (Brundin et al. 1985; Kordower et al. 1998; Zawada et al. 1998; Hagell and Brundin 2001) . Around 20 30% of the mesencephalic cells already die during the preparation of donor tissue prior to transplantation (Fawcett et al. 1995; Kaminski Schierle et al. 1999a; Brundin et al. 2000a; Karlsson et al. 2000) , probably due to traumatic and ischemic damage during dissection and dissociation procedures. Another 67 70% of dopaminergic neurones die during the first week post transplantation (Barker et al. 1996; Emgard et al. 1999; Sortwell et al. 2000) . A part of the cell death that accompanies embryonic neuronal transplantation of rat and human cells is apoptotic and associated with the activation of caspases (Branton and Clarke 1999; Schierle et al. 1999; Brundin et al. 2000a) . One method of increasing survival of dopaminergic neurones would be to prevent this form of cell death. Activation of the Jun N terminal kinase (JNK) stress pathway has been shown to be central to apoptotic neuronal cell death in several in vitro and in vivo models (Harper and LoGrasso 2001) . More specifically, activation of JNK has been demonstrated in in vitro and in in vivo models of dopaminergic neuronal death (Choi et al. 1999; Saporito et al. 2000; Chun et al. 2001; Gearan et al. 2001) . CEP 1347 and CEP 11004 are mixed lineage kinase (MLK) inhibitors that have been found to be protective in a number of in vitro models and in an in vivo dopaminergic neuronal degeneration model (Maroney et al. 1998 Saporito et al. 1999; Bozyczko Coyne et al. 2001; Harris et al. 2002b; Murakata et al. 2002) . Notably, these inhibitors do not inhibit JNK activity directly in cells but rather, act upstream by inhibiting the family of MLKs, a class of mitogen activated protein kinase kinase kinases activated by stress and cytokines . A critical role for MLK activation in JNK mediated neuronal apoptotic death has been demonstrated (Xu et al. 2001 ). Here we use the MLK inhibitor CEP 1347 to elucidate the role of MLK in the survival of embryonic dopaminergic neurones in culture and following transplantation into the denervated striatum of hemiparkinsonian rats.
Experimental procedures

Materials
Dulbecco's modified Eagle's medium (DMEM), Hank's balanced salt solution (HBSS) without calcium and magnesium, HEPES, sodium pyruvate, penicillin/streptomycin, fetal bovine serum and horse serum were purchased from Gibco BRL (Invitrogen, Taastrup, Denmark). Trypsin was purchased from Worthington Biologicals Corporation (Medinova Scientific A/S, Hellerup, Denmark). Laza roid (U74389G), poly L lysine, DNase and all other chemicals were purchased from Sigma (Vallensbaek Strand, Denmark). Laboratory Tek chamber slides were purchased from Nunc A/S (Roskilde, Denmark). Hoechst 33342 was purchased at Molecular Probes (Leiden, the Nederlands). Mouse anti tyrosine hydroxylase (TH) monoclonal antibody was purchased from Chemicon (Chandlers Ford, UK). The 'c jun activation hit kit', was purchased from Cellomics (Pittsburgh, PA, USA). The p c jun and p JNK mouse monoclonal antibodies were from Santa Cruz Biotecnology (Santa Cruz, CA, USA). Normal horse serum and biotinylated horse anti mouse IgG (H + L) were purchased from Vector Laboratories (VWR International, Albertslund, Denmark). Horseradish peroxi dase conjugated anti mouse antibody, Avidin biotin peroxidase complex system [ABComplex/horseradish peroxidase (HRP)] and 3,3¢ diaminobenzidine (DAB) chromogen were purchased from DAKO (Glostrup, Denmark). ECL Plus reagent was purchased from Amersham (Arlington Heights, IL, USA). JNK inhibitor I peptide and SP600125 were purchased from Calbiochem (Bie & Berntsen, Roedovre, Denmark). CEP 1347 and CEP 11004 were kindly provided by Cephalon (West Chester, PA, USA).
Animals
Ventral mesencephalon (VM) tissue was derived from E14 Sprague Dawley rat embryos (Taconic M & B, Ry, Denmark) . In all in vivo experiments, adult female Sprague Dawley rats (Taconic M & B) weighing 220 250 g at the beginning of the experiment were used. Two animals per cage were housed at a 12 h day/night cycle with access to food and water ad libitum. All experimental procedures were carried out in accordance with the directives of the Danish National Committee on Animal Research Ethics and the European Communities Council Directive #86/609 for care of laboratory animals.
Experiments in PC12 cells PC12 cells (ATCC CRL 1721; Greene and Tischler 1976) were maintained in DMEM supplemented with 10% heat inactivated horse serum, 5% heat inactivated fetal bovine serum, 1% sodium pyruvate and 1% penicillin/streptomycin. For experiments, cells were plated in collagen G coated, 6 well plates with 100 000 cells/ mL (2 mL/well) and left overnight to adhere. The medium was then replaced with medium containing 2% serum (DMEM plus 1% heat inactivated horse serum and 1% heat inactivated fetal bovine serum). MnCl 2 (1 mM) and CEP 1347/CEP 11004 (30 500 nM) were added. For immunocytochemistry, cells were fixed in 3.7% formaldehyde after 6 h and stained for p c jun according to the manufacturer's protocol (c jun activation hit kit). Immunoreactivity was visualized using an Alexa Fluor 488 conjugated secondary antibody included in the kit. Nucleus intensity was determined by image processing software using the 'cytoplasm to nucleus translocation' algorithm on the CCD camera based ArrayScan HCS system (Cellomics). Eight wells were used for one data point, and 200 800 cells were analysed per well.
To quantify the effect of CEP 11004 on Mn 2+ induced cell death, cells were stained with the fluorescent dye Hoechst 33342 and the number of apoptotic nuclei was scored by use of fluorescence microscopy. Cells with condensed and fragmented nuclei were scored as apoptotic. For western blotting, cells were lysed after 16 h in 200 lL lysis buffer (10 mM Tris HCl (pH 7.2), 1% NP40, 1 mM AEBSF), and 10 lg protein were loaded onto 10% sodium dodecyl sulfate (SDS) polyacrylamide gels. Proteins were transferred to polyvinylidene difluoride (PVDF) membranes and analysed by phospho specific antibodies against p JNK (1 : 1000) and p c jun (1 : 1000) followed by a HRP conjugated anti mouse antibody. Labelled proteins were detected using ECL Plus reagent.
Preparation of primary rat ventral mesencephalic cell cultures or suspensions Primary dopaminergic neurones from rat embryonic ventral mesen cephalon (VM) were prepared as previously described (Kaminski Schierle et al. 1999b) . Briefly, VM tissue was dissected from 14 day old rat embryos and kept in ice cold HBSS. The tissue was trypsinized in a solution containing 0.1% (wt/vol) trypsin and 0.05% (wt/vol) DNase dissolved in HBSS. After 20 min incubation at 37°C, the tissue was rinsed four times in a 0.05% DNase HBSS solution. The tissue was mechanically dissociated into a cell suspension. The cells were either used as suspension for transplan tation or seeded on poly L lysine (50 mg/L) coated plates for in vitro experiments. For culture experiments, neurones were cultured in DMEM containing 1 mM sodium pyruvate, 15 mM HEPES, 1% penicillin/streptomycin and 10% (v/v) heat inactivated fetal bovine serum. Alternatively, the neurones were cultured in Neurobasal medium supplemented with B27, 0.5 mM L glutamine and 1% penicillin/streptomycin. The cells were seeded in eight well cham ber slides at a density of 62 500 150 000 cells/cm 2 . Cultures were maintained at 37°C in a humidified atmosphere of 5% CO 2 . Cultures were used for up to 7 days in vitro (DIV).
In the graft study, some cell suspensions were treated with CEP 1347 (1 lM) during each step of the procedure, including the tissue dissection and dissociation. In all cases, special care was taken to balance the number of embryos and the volumes of solutions to obtain cell suspensions with similar cell concentration.
Cell death models in VM cultures
Three different models were used for in vitro experiments. For each model, two to four independent culture experiments were performed. The first model was a 30 48 h culture model that mimics the conditions of the cells during the first phase of a transplantation experiment when there is the highest percentage of cell death (Fawcett et al. 1995; Kaminski Schierle et al. 1999a) . The VM derived cells were plated on chamber slides in medium (DMEM plus 10% serum) containing different concentrations of test compound (CEP 1347). The indicated concentrations of CEP 1347 were also present during all preparation steps, from tissue dissection to plating. When cells had firmly adhered, i.e. 30 48 h after plating, the cultures were fixed with 4% paraformaldehyde and stained using an antibody against TH. Immunoreactivity was detected using an ABComplex/HRP system and DAB was used as chromogen.
The second model was designed to mimic the conditions of the transplanted cells once they are in the adult brain and slow death occurs due to lack of growth factor support (Engele 1998) . Briefly, after 2 DIV, the medium was changed to serum free medium containing various concentration of CEP 1347 (0 1000 nM). After 7 DIV, cultures were fixed with 4% paraformaldehyde and proc essed for immunostaining of TH. Cultures fixed after 2 DIV served as a control for 100% survival. After 7 DIV, the survival of dopaminergic neurones in the culture was reduced to 15 20%.
The third model was an ageing related slow degeneration model, where test compounds were added to the culture 1 h after plating of the cells. For these experiments, the medium was changed to Neurobasal medium plus supplements and test compound after 1 day in culture. Every third day, two thirds of the medium was changed. After 6 7 DIV, the cultures were fixed and immunostained as described above.
In all models, the experimental endpoint was the number of TH immunopositive neurones/culture. For each experimental group, four to eight culture wells were scored with regard to the number of TH immunopositive neurones. The number of TH immunopositive neurones was counted on blind coded slides using a semi automated stereological cell counting system (Computer Assisted Stereological Test Grid System: Olympus C.A.S.T. Grid system, Albertslund, Denmark) as described previously (Schierle et al. 1999) .
Activation of the JNK pathway in VM cultures
For western blotting, cells from model 1 were lysed after 24 h in 200 lL lysis buffer (10 mM Tris HCl (pH 7.2), 1% NP40, 1 mM AEBSF), and 10 lg protein were loaded onto 4 12% SDS polyacrylamide gels. Proteins were transferred to PVDF membranes and analysed by phospho specific antibodies against p JNK (1 : 1000) and p c jun (1 : 1000), followed by a HRP conjugated anti mouse antibody. Labelled proteins were detected using ECL Plus reagent.
Unilateral 6 hydroxydopamine lesion and motor asymmetry test For all surgical procedures, the rats were anaesthetized with a mixture of Hypnorm (fentanyl/fluanisone, Janssen Pharmaceutical, Belgium) and Dormicum (midazolam, Hoffman La Roche, Switzer land). The anaesthetic mixture was prepared with 25% Hypnorm and 25% Dormicum in sterile distilled water and administered as 2.7 mL/ kg BW s.c. For post operational analgesia the rats received Temgesic (0.3 mg/mL buprenorphine, Schering Plough, Farum, Denmark) 1 mL/kg BW s.c. of a 1 : 3 diluted (with sterile saline) solution.
Female Sprague Dawley rats were subjected to unilateral 6 hydroxydopamine (6 OHDA) lesion of the ascending mesostriatal dopamine pathway as described previously (Grasbon Frodl et al. 1996) . Three weeks post lesion the effect of the 6 OHDA injury was assessed by monitoring amphetamine (D amphetamine sulphate 2.5 mg/kg, i.p.) induced turning behaviour (Ungerstedt and Arbuthn ott 1970) . Rats exhibiting a net rotation asymmetry (turns contralat eral to the lesion subtracted from ipsilateral turns) of at least seven full turns/min were selected for transplantation surgery. Using a 5 mg/kg dose of amphetamine, this turning rate corresponds to a striatal dopamine depletion of ‡ 97% (Schmidt et al. 1983 ). The rotation test was repeated at 2 and 5 weeks after the transplantation surgery.
Transplantation surgery and administration of compound CEP 1347 was dissolved in a 7.5% solutol/phosphate buffered saline (PBS) vehicle. Vehicle treated rats received a daily injection of the same volume (2 mL/kg) of vehicle. Vehicle/compound admin istration was started 1 week prior to transplantation and continued until the day before termination 5 weeks post transplantation.
In a single transplantation session, two deposits of 1.5 lL of the cell suspension (in total approximately 250 000 cells equivalent to 50% of one VM) were injected stereotaxically into the right (lesioned) striatum of recipient rats as described previously (Grasbon Frodl et al. 1996) and at the following co ordinates (from bregma): A 1.0, L 3; V ) 5 and ) 4.5 mm, Tooth Bar ) 3.3.
Histological assessment
Five weeks after transplantation the rats were deeply anaesthetized with Avertin 10 mL/kg (Bie & Berntsen) and perfused through the heart with saline followed by phosphate buffered 4% (w/v) paraformaldehyde. The brains were post fixed for 4 h in the same fixative, cryoprotected in phosphate buffered 30% sucrose, and then sectioned coronally at 40 lm thickness using a cryostat. Brain sections throughout the graft region were collected in three parallel series. One series was reacted for free floating TH immunohisto chemistry with the ABC detection kit and DAB as a chromogen. Sections were mounted on gelatinized slides, air dried, dehydrated in an ascending series of alcohols, cleared with xylene and coverslipped using the mounting medium Pertex (Bie & Berntsen).
The total numbers of TH positive neurones in each graft were stereologically counted on parallel TH immunostained, blind coded slides using the C.A.S.T. Grid system as described previously (Schierle eta/. 1999) . Using the same system and the same slides, graft volumes and fibre outgrowth were also determined using the Cavalieri principle for volume estimation (Maller eta/. 1995; Gregersen et a/. 2000) .
Statistics
Cell count data were analysed by one factor ANOVA with group (treatment) as independent variable. Behavioural data that had been collected on several testing sessions pre and post grafting were analysed using repeated measures ANOVA, where time (testing session) and group (treatment) were entered as independent variables. All posthoc comparisons were carried out using the Tukey ' honestly significant difference' method or, when the data distnbution was not normal, the Kruskal Wallis one way ANOVA on Ranks and Dunn's method. Statistical significance was set at p < 0.05. Data are expressed as group means ± SD or SEM with indication of the sample size.
Results
Enhancement by CEP-1347 ofthe survival of cultured dopamioergic neurones prepared for transpla ntation First, it was tested whether CEP 1347 had an effect on embryonic dopaminergic cells in conditions simulating the initial phase of the transpJantation protocol. After the cell preparation, which is a major cell death inducing stress within the transplantation procedure, the cells were short term cultured in serum containing medium, i.e. optimal culture conditions, and analysed after 40 h. CEP 1347 treatment during preparation and after plating resulted in an increase in TH positive neurones, which was already signi ficant at concentrations as low as 30 OM and reached a maximal effect at 500 OM (Fig. 1a) .
We further investigated whether CEP 1347 acts on its supposed target pathway in this cellular model. We found that 24 h after plating, JNK was highly activated as detected by phospho specific antibodies for phospho JNK. In cultures prepared and maintained in the presence of CEP 1347, activation of the JNK pathway was reduced by 83%, as quantified by densitometry and beta actin normalization (Fig. I b) .
Enhancement of survival by CEP-1347 in serun1-depleted neurones
In the second set up, cell cultures were stressed by serum withdrawal. This lack of trophic factor resembles the second phase of the transplantation protocol, where the cells have been transplanted but lack the trophic support of their natural environment It was found that CEP 1347 (30 1000 OM), when given during the period of serum withdrawal, signi ficantly increased the number of TH positive neurones compared to cultures treated with medium alone. Maximal protection was observed at I 00 OM (Fig. 2) . 
Protection by CEP-1347 from ageing-induced cell death
In the third model, cells were cultured for 7 DIV, and we examined the ability of CEP 1347 to improve overall survival and differentiation of dopaminergic neurones. After 7 DIV, cultures receiving CEP 1347 showed highly increased TH immunoreactivity compared with control cultures (Fig. 3) . Most of the increased staining was due to an increased number of TH immunopositive neurones, which was significantly increased by 50 1000 nM of CEP 1347 and more than threefold at 1000 nM (Fig. 4) . When looking at individual TH positive neurones, it was evident that drug treatment did not reduce the extent or complexity of the neurite network. On the contrary, CEP 1347 treated neurones often appeared to display a more healthy and complex neuronal morphology (Fig. 3 ). In this model, we also tested the effect of direct inhibition of JNK in order to compare it with the effect of the upstream MLK inhibitor CEP 1347 (Ip and Davis 1998) . For this purpose, two commercially available inhibitors of JNK were tested. SP600125 at 10 lM, but not 1 lM, significantly increased the number of TH positive neurones comparable to the increase observed with CEP 1347 (Fig. 4) . By contrast, the cell permeable peptide, JNK inhibitor I (1 or 10 lM), did not increase TH immuno reactivity (data not shown). Finally, in this same model, the effects of CEP 1347 were compared with those of a lazaroid (Nakao et al. 1994; Hall 1997) , the only drug class used for enhancement of cell survival in human transplantation (Brundin et al. 2000b) . It was examined whether the lazaroid U74389G would protect TH positive neurones from death induced by ageing in culture. Lazaroid (0.3 10 lM) treated cultures did not show any improvement in survival from control cultures (Fig. 4) , clearly indicating higher efficacy of CEP 1347 to rescue cells in this model.
Generally protective effects of MLK inhibition in transplantation-linked dopaminergic cell stress CEP 11004, a second selective MLK inhibitor suitable for culture studies, has recently been described (Murakata et al. 2002) . We took advantage of the availability of this tool to obtain independent proof for the role of the MLK pathway in dopaminergic cell death. The main cell culture experiments were repeated in the presence of CEP 11004 instead of CEP 1347 and similar protection was observed (Fig. 5) .
As a further approach to address the role of the MLK pathway for dopaminergic cell death, we used a model of Mn 2+ induced stress in PC12 cells. The oxidative stress caused by Mn 2+ models the stress supposedly occurring during transplantation, and the PC12 cell line offers the advantaged of a homogenous cell preparation. Treatment with MnCh activated JNK and caused activation of c jun, and this was blocked by both CEP 134 7 and CEP 11 004 (Fig. 6 ). These results obtained by western blotting were confirmed by single cell immunofluorescence analysis, which clearly showed that CEP 11 004 completely blocked the Mn 2 + triggered phospho c jun translocation from cytoplasm to the nucleus. Block of c jun activation was paralleled by a significant decrease in apoptotic cell death.
Effects of t reatmen t wit h CEP-1347 on the survival a nd function of d opaminergic neurones in mesencephalic grafts
We tested whether treatment of a VM cell suspension with CEP 1347 would enhance the survival of dopaminergic neurones after intrastriatal grafting, and whether treatment of In all animals that received intrastriatal injection of VM cell suspensions, we detected at 5 weeks post grafting the presence of large grafts in the striatum containing TH immunopositive neurones (not illustrated). Although in all animals the main body of the grafts was in the striatum, in several of them the grafts were not completely contained within this structure, and also extended into the overlying cerebral cortex. In all animals, a dense network of TH immunopositive fibres extended from the graft into the surrounding striatum and cerebral cortex (not illustrated).
Stereological counts of TH positive neurones showed that there was a higher number of surviving dopaminergic neurones in all animals of the CEP 1347 treated groups compared with those of the vehicle group. This increase in survival was most distinct (> 250% more neurones) for the group with combined treatment of the cell suspension and daily host administration of CEP 1347 ('CEP 1347 cells plus host'). This observed significant increase in survival was due to a clear increase in the mean number of surviving neurones (Fig. 7a) , as well as to a substantial decrease in the variability in number of surviving neurones in different animals (3276 ± 1043 cells in vehicle group vs. 8297 ± 404 in the 'CEP 1347 cells plus host' group). When graft volumes were examined, we found a clear graft increasing effect of CEP 1347 treatment of the recipient rats (Fig. 7b) , reaching a significance level in the 'CEP 1347 cell plus host' group in comparison with the vehicle group and the 'CEP 1347 cells' group. We also examined the extent of outgrowth of TH positive fibres from the grafts and found that this parameter was also improved by CEP 1347 treatment of recipient rats, although not to significance level, most likely because of some variability of this parameter (data not shown). We further tested whether CEP 1347 treatment would result in enhanced functional recovery as detected in the amphetamine induced rotation test. At 2 weeks post transplantation, all grafted groups showed a decrease in their rotation score compared with the pre operation values, with a reduction to around 75% of the pre transplantation score in the vehicle group and up to around 50% in the group where both cell suspension and host were treated with compound. At 5 weeks post transplantation, all groups exhibited reversal of motor asymmetry. This is an indication that in all rats there were very large functioning transplants (confirming the data of the counts of TH positive neurones and measurement of graft size reported in Fig. 7a and b) . A bigger negative score (¼ contralateral rotations) indicates a larger transplant. Also, at this survival time the group with suspension plus recipient treated with CEP 1347 showed a trend towards better performance than vehicle treated rats (Fig. 7c) . Statistical analysis of group time interaction, however, indicated that extent and rate of recovery between 2 and 5 weeks were not significantly different between the grafted groups (two factors ANOVA, effect of group p > 0.05).
Discussion
In this study we have shown that CEP 1347, an MLK inhibitor, improves the survival of primary embryonic dopaminergic neurones both in culture in four different stress models and in vivo after transplantation into the denervated striatum of adult hemiparkinsonian rats. In this last condition, to obtain the best survival of the transplanted dopaminergic neurones, it is necessary to combine treatment of the cell suspension and of the host. We also showed that in PC12 cells and in VM cultures exposed to stress similar to that during graft preparation, there is activation of the JNK pathway, which is inhibited by both CEP 1347 and CEP 11004.
CEP 1347 and CEP 11004 were neuroprotective against a wide range of insults. The extent of beneficial effects of the MLK inhibitors was in the same range as that reported for established neuroprotectants for embryonic dopaminergic neurones, members of the lazaroid family [our data and Karlsson et al. (2002) ] and caspase inhibitors (Schierle et al. 1999; Hansson et al. 2000) . This suggests that MLK mediated JNK activation is a critical upstream event in stress induced death of primary embryonic dopaminergic neurones. It is a point of concern that inhibition of JNK may also have negative effects on neurones by preventing physiolo gical and differentiation signals. However, in our in vitro experiments, the cultures treated with CEP 1347 looked morphologically indistinguishable from control cultures or, frequently, even 'healthier', i.e. displaying a larger and more elaborate neurite network. Similar results have been obtained in trophic factor deprived sympathetic neurones (Harris et al. 2002b) . A possible reason for this is that CEP 1347 does not block JNK directly, but block only one of several JNK activation pathways. MLK inhibitors specifically block suprabasal stress induced JNK activity while leaving the physiological basal cellular JNK activity intact (Mielke and Herdegen 2002) . It has recently been shown that one of the mechanisms by which protein kinase B/AKT promotes cell survival is via phosphorylation of MLK3, leading to its inhibition (Barthwal et al. 2003) . Thus, inhibition of MLK may be a very 'physiological' way of blocking cell death, leading to only minimal disruption of other vital cell pathways.
In our study, we showed that MLK inhibition improves the survival of primary dopaminergic neurones not only in culture but also after grafting in the adult brain. We obtained the best protection with combined treatment of the suspen sion and of the host. With this combined treatment the percentage of surviving neurones in comparison with controls was similar to that obtained by combined treatment of lazaroid plus caspase inhibitors (Hansson et al. 2000) , or of caspase inhibitors and complement inhibition (Cicchetti et al. 2002) . This suggests that MLK inhibition can block several of the mechanisms involved in the death of transplanted neurones both during the very first phase of transplantation and later when the neurones are long term exposed to the adult CNS environment. We also found that the neuroprotective action of CEP 1347 is not only restricted to the dopaminergic neurones but also to other cells present in the graft, since we detected a significant increase in total graft size with compound treatment. Again, we found that treatment of the host was critical for this effect, since the group with combined treatment had significantly larger grafts than both the control and the 'CEP 1347 cells' groups. The fact that treatment of the host is critical for best protection may indicate the need for continuous exposure of the grafted neurones to the inhibitor to block their death. It may also imply that the compound has some effects on the brain milieu surrounding the graft, increasing its permis siveness to cell survival, and this will require further investigation. There was also a trend towards a positive effect of CEP 1347 on the fibre outgrowth and on functional outcome of the grafting procedure. However, our study was focused on the clearly measurable survival effect and was not designed and powered to examine functional effects, which depend on many experimental parameters specific for the model chosen. The position of the grafts in our study was not completely contained in the striatum and thus, not in the best location for optimal fibre outgrowth. Moreover, for functional studies, the number of transplanted cells needs to be carefully titrated down so that untreated grafts remain too small to yield full reversal of rotational asymmetry. As shown by our rotation experiments, even control grafted animals compensated after 5 weeks, which indicates potent, possibly saturating graft function without drug treatment.
Comparison of the number of grafted neurones with the number of survivors after 5 weeks shows that even after CEP 1347 treatment, the majority of grafted dopaminergic neurones still die (52.6%, determined as described in Nakao et al. 1994) . This may be due to the fact that MLK inhibition does not block all types of JNK mediated cell death (Salehi et al. 2002) , or that other death pathways are involved. On the other hand, as has been shown for cultured cerebellar granule cells (Harris et al. 2002a) , inhibition of death pathways in the absence of activation of survival pathways may not be sufficient for long term survival of the grafted neurones. Further studies with combined treatment of grafts (and ideally also their hosts) with drugs able to act on all these mechanisms are necessary to answer these ques tions.
Finally, it has also been shown that transplantation prevents the differentiation of dopaminergic precursors present in the grafts into a dopaminergic phenotype (Sinclair et al. 1999) . Treatments aimed at promoting such differen tiation, combined with a treatment to promote survival and/or block death of the grafted neurones, may thus be necessary to obtain the best outcome of the grafting procedure.
CEP 1347 has been found to be neuroprotective in animal models of PD (Saporito et al. 1999) and is a compound currently in clinical Phase 2 trials for PD. Thus, it is attractive to speculate that when used in clinical practice to promote survival of dopaminergic neurones grafted in parkinsonian patients it may, as a bonus, protect the dopaminergic neurones of the grafted host, leading to long term improve ment of the disease.
